Affordable Access

Defining polysaccharide antibody deficiency: measurement of anti-pneumococcal antibodies and anti-Salmonella typhi antibodies in a cohort of patients with recurrent infections

  • Bucciol, Giorgia; 115768;
  • Schaballie, Heidi;
  • Schrijvers, Rik; 60298;
  • Bosch, Barbara;
  • Proesmans, Marijke; 3457;
  • De Boeck, Christiane;
  • Boon, Mieke; 59890;
  • Vermeulen, François; 58463;
  • Lorent, Natalie;
  • Dillaerts, Doreen; 76014;
  • Kantsø, Bjørn;
  • Jørgensen, Charlotte S;
  • Emonds, Marie-Paule; 40733;
  • Bossuyt, Xavier; 9916;
  • Moens, Leen; 44303;
  • Meyts, Isabelle; 35063;
Publication Date
Nov 08, 2019
External links


Background: The correlation between different methods for the detection of pneumococcal polysaccharide vaccines (PPV) responses to diagnose specific polysaccharide antibody deficiency (SAD) is poor and the criteria for defining a normal response lack consensus. We previously proposed fifth percentile (p5) values of PPV responses as a new cutoff for SAD. Objective: To analyze the association of SAD (determined by either World Health Organization (WHO)-standardized ELISA or multiplex bead-based assay) with abnormal response to Salmonella (S.) typhi Vi vaccination in a cohort of patients with recurrent infections. Methods: Ninety-four patients with a clinical history suggestive of antibody deficiency received PPV and S. typhi Vi vaccines. Polysaccharide responses to either 3 or 18 pneumococcal serotypes were measured by either the WHO ELISA or a multiplex in-house bead-based assay. Anti-S. typhi Vi IgG were measured by a commercial ELISA kit. Allohemagglutinins (AHA) were measured by agglutination method. Results: Based on American Academy of Allergy, Asthma and Immunology (AAAAI) criteria for WHO ELISA, 18/94 patients were diagnosed with SAD and 22/93 based on serotype-specific p5 cutoffs for bead-based assay. The association between the two methods was significant, with 10 subjects showing abnormal response according to both techniques. Abnormal response to S. typhi Vi vaccination was found in 7 patients, 6 of which had SAD. No correlation was found between polysaccharide response and AHA, age or clinical phenotype. Conclusion: The lack of evidence-based gold standards for the diagnosis of SAD represents a challenge in clinical practice. In our cohort, we confirmed the insufficient correlation between different methods of specific PPV response measurement, and showed that the S. typhi Vi response was not contributive. Caution in the interpretation of results is warranted until more reliable diagnostic methods can be validated. / status: accepted

Report this publication


Seen <100 times